News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
131,204 Results
Type
Article (7597)
Company Profile (57)
Press Release (123547)
Multimedia
Podcasts (21)
Webinars (5)
Section
Business (38469)
Career Advice (89)
Deals (5995)
Drug Delivery (10)
Drug Development (23814)
Employer Resources (12)
FDA (3061)
Job Trends (3590)
News (69221)
Policy (4617)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (328)
Accelerated approval (12)
Adcomms (13)
Allergies (3)
Alliances (11293)
ALS (21)
Alzheimer's disease (162)
Antibody-drug conjugate (ADC) (247)
Approvals (3216)
Artificial intelligence (166)
Autoimmune disease (50)
Automation (5)
Bankruptcy (55)
Best Places to Work (3303)
BIOSECURE Act (1)
Biosimilars (88)
Biotechnology (50)
Bladder cancer (126)
Brain cancer (46)
Breast cancer (481)
Cancer (3478)
Cardiovascular disease (35)
Career advice (82)
Career pathing (5)
CAR-T (123)
CDC (3)
Cell therapy (261)
Cervical cancer (18)
Clinical research (21219)
Collaboration (670)
Company closure (2)
Compensation (211)
Complete response letters (10)
COVID-19 (352)
CRISPR (25)
C-suite (284)
Cystic fibrosis (8)
Data (2235)
Decentralized trials (1)
Denatured (3)
Depression (11)
Diabetes (38)
Diagnostics (1401)
Digital health (6)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (92)
Drug pricing (25)
Drug shortages (1)
Duchenne muscular dystrophy (27)
Earnings (13937)
Editorial (12)
Employer branding (2)
Employer resources (13)
Events (24865)
Executive appointments (314)
FDA (3892)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (2)
Funding (324)
Gene editing (42)
Generative AI (15)
Gene therapy (89)
GLP-1 (126)
Government (486)
Guidances (87)
Healthcare (4063)
HIV (7)
Huntington's disease (3)
IgA nephropathy (17)
Immunology and inflammation (70)
Immuno-oncology (56)
Indications (51)
Infectious disease (389)
Inflammatory bowel disease (35)
Inflation Reduction Act (3)
Influenza (14)
Intellectual property (54)
Interviews (12)
IPO (2992)
IRA (8)
Job creations (483)
Job search strategy (70)
JPM (25)
Kidney cancer (16)
Labor market (8)
Layoffs (139)
Leadership (6)
Legal (477)
Liver cancer (48)
Longevity (1)
Lung cancer (516)
Lymphoma (222)
Machine learning (14)
Management (3)
Manufacturing (132)
MASH (6)
Medical device (876)
Medtech (880)
Mergers & acquisitions (3259)
Metabolic disorders (104)
Multiple sclerosis (15)
NASH (1)
Neurodegenerative disease (30)
Neuropsychiatric disorders (9)
Neuroscience (318)
NextGen: Class of 2026 (955)
Non-profit (499)
Now hiring (17)
Obesity (58)
Opinion (38)
Ovarian cancer (130)
Pain (27)
Pancreatic cancer (164)
Parkinson's disease (31)
Partnered (1)
Patents (90)
Patient recruitment (153)
Peanut (2)
People (13479)
Pharmaceutical (12)
Pharmacy benefit managers (3)
Phase 1 (8016)
Phase 2 (8874)
Phase 3 (6841)
Pipeline (1628)
Policy (33)
Postmarket research (472)
Preclinical (2533)
Press Release (2)
Prostate cancer (168)
Psychedelics (4)
Radiopharmaceuticals (186)
Rare diseases (142)
Real estate (751)
Recruiting (5)
Regulatory (4756)
Reports (8)
Research institute (696)
Resumes & cover letters (11)
RNA editing (2)
RSV (10)
Schizophrenia (36)
Series A (65)
Series B (29)
Service/supplier (1)
Sickle cell disease (37)
Special edition (3)
Spinal muscular atrophy (16)
Sponsored (6)
Startups (767)
State (1)
Stomach cancer (12)
Supply chain (12)
Tariffs (8)
The Weekly (18)
Vaccines (185)
Venture capital (34)
Weight loss (25)
Women's health (5)
Date
Today (5)
Last 7 days (156)
Last 30 days (571)
Last 365 days (8341)
2026 (809)
2025 (8405)
2024 (9468)
2023 (10641)
2022 (13111)
2021 (13178)
2020 (10961)
2019 (8593)
2018 (6335)
2017 (7126)
2016 (6284)
2015 (6951)
2014 (4527)
2013 (3091)
2012 (3343)
2011 (3329)
2010 (3038)
Location
Africa (88)
Alabama (19)
Alaska (1)
Arizona (25)
Arkansas (2)
Asia (11395)
Australia (1538)
California (3098)
Canada (704)
China (589)
Colorado (81)
Connecticut (128)
Delaware (237)
Europe (20750)
Florida (407)
Georgia (12)
Idaho (6)
Illinois (304)
India (18)
Indiana (99)
Iowa (9)
Japan (205)
Kansas (10)
Kentucky (13)
Maine (4)
Maryland (336)
Massachusetts (2456)
Michigan (26)
Minnesota (109)
Missouri (11)
Montana (7)
Nebraska (2)
Nevada (10)
New Hampshire (10)
New Jersey (879)
New Mexico (3)
New York (740)
North Carolina (235)
Northern California (1637)
Ohio (65)
Oklahoma (1)
Oregon (5)
Pennsylvania (459)
Puerto Rico (2)
Rhode Island (6)
South America (117)
South Carolina (3)
Southern California (1221)
Tennessee (36)
Texas (535)
United States (10460)
Utah (75)
Virginia (24)
Washington D.C. (9)
Washington State (291)
Wisconsin (35)
131,204 Results for "alopexx oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Alopexx Announces Presentation at IDWeek 2023
Alopexx, Inc. is scheduled to present pre-clinical data at IDWeek 2023’s Microbial Pathogenesis of Alzheimer’s Disease symposium being held October 11-15, 2023 in Boston, MA.
October 11, 2023
·
3 min read
Genetown
Alopexx to Present Data on F598, a Novel, Broad-Spectrum Immunotherapeutic at IDWeek 2023
Alopexx, Inc. today announced that Daniel Vlock, MD, Co-Founder, Chief Executive Officer and Chairman of the Board of Alopexx, is scheduled to present at IDWeek’s 2023’s New Antimicrobials in the Pipeline symposium being held October 11-15, 2023 in Boston, MA.
October 12, 2023
·
3 min read
Press Releases
Alopexx Announces Investment from Biotech Consortia, Inc.
September 6, 2024
·
4 min read
Cancer
JPM26: AbbVie Seeks Respect for Oncology Pipeline Following RemeGen Buy
Primarily known as an immunology and neuroscience company, AbbVie wanted to put the biopharma world on notice during its J.P. Morgan presentation: its oncology portfolio is underappreciated. This week, the Illinois-based company dove into the sizzling PD-1/VEGF space with a licensing deal with China-based RemeGen.
January 14, 2026
·
2 min read
·
Heather McKenzie
Job Trends
9 Companies Hiring in Oncology
Looking for a job in oncology? Check out the
BioSpace
list of nine companies hiring life sciences professionals like you.
October 9, 2025
·
2 min read
·
Angela Gabriel
Business
Alopexx Announces Collaboration with Bharat Biotech for the Development and Commercialization of Broad-Spectrum Anti-Microbial Vaccine AV0328
September 10, 2024
·
6 min read
Sponsored
Disruptive Innovation in Cancer Research: The New Era of Oncology
As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel methodologies, strategic innovation, and patient-centered approaches, MEDSIR is driving a new era in cancer research, one that accelerates development, enhances efficiency, and delivers more meaningful therapeutic progress for patients worldwide.
December 15, 2025
·
9 min read
Press Releases
Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP Platform
January 5, 2026
·
6 min read
Press Releases
Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S.-Based LumaBridge and Establishes New Oncology Center of Excellence
January 7, 2026
·
3 min read
Press Releases
Olema Oncology to Participate in Upcoming February 2026 Investor Conferences
February 5, 2026
·
1 min read
1 of 13,121
Next
